In multivariate analysis , high tissue mRNA of angiogenic VEGF-Axxxa in the presence of bevacizumab therapy predicted for favorable progression-free survival ( HR for progression , @ ; P = @ ) and OS ( HR for death , @ ; P = @ ) .